WuXi Biologics grants restricted shares under award scheme

WuXi Biologics (HKEX:2269) announced the grant of 25,520,857 Restricted Shares under its Restricted Share Award Scheme, effective March 26, 2025. The grant includes 24,210,392 shares allocated to 1,911 employees of the Group and 1,310,465 shares to Dr. Chen. The purchase price for the restricted shares is nil, with the market price on the grant date at HK$26.20 per share. Vesting will occur in stages, with 20% vesting on each of the second, third, and fourth anniversaries of the grant date, and the remaining 40% vesting on the fifth anniversary. The grant is subject to a clawback mechanism under certain conditions, such as termination for cause or a criminal conviction. Post-grant, 186,969,826 shares remain available for future grants under the Scheme Mandate Limit.